Freestone Grove Partners LP Bristol Myers Squibb CO Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
A detailed history of Freestone Grove Partners LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Freestone Grove Partners LP holds 15,468 shares of BMY stock, worth $850,430. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,468Holding current value
$850,430% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,749Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.72 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.28 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.23 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.32 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $117B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...